Life Healthcare's share price fell 8% to R24 on Friday morning after its upbeat trading statement failed to meet the high expectations of investors. The private-hospital owner said it expected to report on November 23 that its headline earnings per share (HEPS) for the year to end-September grew up to 45%, and basic earnings per share up to 77%. It achieved this growth per share despite its number of shares in issue increasing 11% following a rights offer in April. Life Healthcare said its UK subsidiary, Alliance Medical, would boost its 2018 financial year thanks to the rand weakening against the pound and its inclusion for the full year as opposed to only 10 months in the prior year's results. The coming results would show its overall revenue grew about 12% to R23bn, with its Southern African revenue growing about 8.5% to about R17.2bn, its UK revenue growing about 30% to R5bn, and its Polish revenue growing about 14.5% to R1.2bn. laingr@businesslive.co.za

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.